Summary
The global Granisetron Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Granisetron Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Granisetron Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Kyowa Kirin
- Heron Therapeutics
- Fresenius Kabi
- Hikma Pharmaceuticals
- Teva
- Cipla
- Sandoz
- Wockhardt
- Mylan
- APOTEX
- Dr.Reddy's
- Bluepharma
- Natco Pharma
- Akorn
- Taro Pharmaceutical
- Aurobindo
By the Product Type, the market is primarily segmented into:
- Transdermal system
- Injection
- Oral
By Applications, the market is segmented into:
- Chemotherapy
- Post operative
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Granisetron Market Report:
- To assess the size of the market by value and volume
- Analyze the Granisetron Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Granisetron Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Granisetron Market
The Granisetron Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Granisetron Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Granisetron Revenue
1.4 Market Analysis by Type
1.4.1 Global Granisetron Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transdermal system
1.4.3 Injection
1.4.4 Oral
1.5 Market by Application
1.5.1 Global Granisetron Market Share by Application: 2020 VS 2026
1.5.2 Chemotherapy
1.5.3 Post operative
1.6 Coronavirus Disease 2019 (Covid-19): Granisetron Industry Impact
1.6.1 How the Covid-19 is Affecting the Granisetron Industry
1.6.1.1 Granisetron Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Granisetron Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Granisetron Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Granisetron Market Perspective (2015-2026)
2.2 Granisetron Growth Trends by Regions
2.2.1 Granisetron Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Granisetron Historic Market Share by Regions (2015-2020)
2.2.3 Granisetron Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Granisetron Market Growth Strategy
2.3.6 Primary Interviews with Key Granisetron Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Granisetron Players by Market Size
3.1.1 Global Top Granisetron Players by Revenue (2015-2020)
3.1.2 Global Granisetron Revenue Market Share by Players (2015-2020)
3.1.3 Global Granisetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Granisetron Market Concentration Ratio
3.2.1 Global Granisetron Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Granisetron Revenue in 2019
3.3 Granisetron Key Players Head office and Area Served
3.4 Key Players Granisetron Product Solution and Service
3.5 Date of Enter into Granisetron Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Granisetron Historic Market Size by Type (2015-2020)
4.2 Global Granisetron Forecasted Market Size by Type (2021-2026)
5 Granisetron Breakdown Data by Application (2015-2026)
5.1 Global Granisetron Market Size by Application (2015-2020)
5.2 Global Granisetron Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Granisetron Market Size (2015-2020)
6.2 Granisetron Key Players in North America (2019-2020)
6.3 North America Granisetron Market Size by Type (2015-2020)
6.4 North America Granisetron Market Size by Application (2015-2020)
7 Europe
7.1 Europe Granisetron Market Size (2015-2020)
7.2 Granisetron Key Players in Europe (2019-2020)
7.3 Europe Granisetron Market Size by Type (2015-2020)
7.4 Europe Granisetron Market Size by Application (2015-2020)
8 China
8.1 China Granisetron Market Size (2015-2020)
8.2 Granisetron Key Players in China (2019-2020)
8.3 China Granisetron Market Size by Type (2015-2020)
8.4 China Granisetron Market Size by Application (2015-2020)
9 Japan
9.1 Japan Granisetron Market Size (2015-2020)
9.2 Granisetron Key Players in Japan (2019-2020)
9.3 Japan Granisetron Market Size by Type (2015-2020)
9.4 Japan Granisetron Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Granisetron Market Size (2015-2020)
10.2 Granisetron Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Granisetron Market Size by Type (2015-2020)
10.4 Southeast Asia Granisetron Market Size by Application (2015-2020)
11 India
11.1 India Granisetron Market Size (2015-2020)
11.2 Granisetron Key Players in India (2019-2020)
11.3 India Granisetron Market Size by Type (2015-2020)
11.4 India Granisetron Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Granisetron Market Size (2015-2020)
12.2 Granisetron Key Players in Central & South America (2019-2020)
12.3 Central & South America Granisetron Market Size by Type (2015-2020)
12.4 Central & South America Granisetron Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Kyowa Kirin
13.1.1 Kyowa Kirin Company Details
13.1.2 Kyowa Kirin Business Overview and Its Total Revenue
13.1.3 Kyowa Kirin Granisetron Introduction
13.1.4 Kyowa Kirin Revenue in Granisetron Business (2015-2020))
13.1.5 Kyowa Kirin Recent Development
13.2 Heron Therapeutics
13.2.1 Heron Therapeutics Company Details
13.2.2 Heron Therapeutics Business Overview and Its Total Revenue
13.2.3 Heron Therapeutics Granisetron Introduction
13.2.4 Heron Therapeutics Revenue in Granisetron Business (2015-2020)
13.2.5 Heron Therapeutics Recent Development
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Details
13.3.2 Fresenius Kabi Business Overview and Its Total Revenue
13.3.3 Fresenius Kabi Granisetron Introduction
13.3.4 Fresenius Kabi Revenue in Granisetron Business (2015-2020)
13.3.5 Fresenius Kabi Recent Development
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Details
13.4.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Hikma Pharmaceuticals Granisetron Introduction
13.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2015-2020)
13.4.5 Hikma Pharmaceuticals Recent Development
13.5 Teva
13.5.1 Teva Company Details
13.5.2 Teva Business Overview and Its Total Revenue
13.5.3 Teva Granisetron Introduction
13.5.4 Teva Revenue in Granisetron Business (2015-2020)
13.5.5 Teva Recent Development
13.6 Cipla
13.6.1 Cipla Company Details
13.6.2 Cipla Business Overview and Its Total Revenue
13.6.3 Cipla Granisetron Introduction
13.6.4 Cipla Revenue in Granisetron Business (2015-2020)
13.6.5 Cipla Recent Development
13.7 Sandoz
13.7.1 Sandoz Company Details
13.7.2 Sandoz Business Overview and Its Total Revenue
13.7.3 Sandoz Granisetron Introduction
13.7.4 Sandoz Revenue in Granisetron Business (2015-2020)
13.7.5 Sandoz Recent Development
13.8 Wockhardt
13.8.1 Wockhardt Company Details
13.8.2 Wockhardt Business Overview and Its Total Revenue
13.8.3 Wockhardt Granisetron Introduction
13.8.4 Wockhardt Revenue in Granisetron Business (2015-2020)
13.8.5 Wockhardt Recent Development
13.9 Mylan
13.9.1 Mylan Company Details
13.9.2 Mylan Business Overview and Its Total Revenue
13.9.3 Mylan Granisetron Introduction
13.9.4 Mylan Revenue in Granisetron Business (2015-2020)
13.9.5 Mylan Recent Development
13.10 APOTEX
13.10.1 APOTEX Company Details
13.10.2 APOTEX Business Overview and Its Total Revenue
13.10.3 APOTEX Granisetron Introduction
13.10.4 APOTEX Revenue in Granisetron Business (2015-2020)
13.10.5 APOTEX Recent Development
13.11 Dr.Reddy's
10.11.1 Dr.Reddy's Company Details
10.11.2 Dr.Reddy's Business Overview and Its Total Revenue
10.11.3 Dr.Reddy's Granisetron Introduction
10.11.4 Dr.Reddy's Revenue in Granisetron Business (2015-2020)
10.11.5 Dr.Reddy's Recent Development
13.12 Bluepharma
10.12.1 Bluepharma Company Details
10.12.2 Bluepharma Business Overview and Its Total Revenue
10.12.3 Bluepharma Granisetron Introduction
10.12.4 Bluepharma Revenue in Granisetron Business (2015-2020)
10.12.5 Bluepharma Recent Development
13.13 Natco Pharma
10.13.1 Natco Pharma Company Details
10.13.2 Natco Pharma Business Overview and Its Total Revenue
10.13.3 Natco Pharma Granisetron Introduction
10.13.4 Natco Pharma Revenue in Granisetron Business (2015-2020)
10.13.5 Natco Pharma Recent Development
13.14 Akorn
10.14.1 Akorn Company Details
10.14.2 Akorn Business Overview and Its Total Revenue
10.14.3 Akorn Granisetron Introduction
10.14.4 Akorn Revenue in Granisetron Business (2015-2020)
10.14.5 Akorn Recent Development
13.15 Taro Pharmaceutical
10.15.1 Taro Pharmaceutical Company Details
10.15.2 Taro Pharmaceutical Business Overview and Its Total Revenue
10.15.3 Taro Pharmaceutical Granisetron Introduction
10.15.4 Taro Pharmaceutical Revenue in Granisetron Business (2015-2020)
10.15.5 Taro Pharmaceutical Recent Development
13.16 Aurobindo
10.16.1 Aurobindo Company Details
10.16.2 Aurobindo Business Overview and Its Total Revenue
10.16.3 Aurobindo Granisetron Introduction
10.16.4 Aurobindo Revenue in Granisetron Business (2015-2020)
10.16.5 Aurobindo Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Granisetron Key Market Segments
Table 2. Key Players Covered: Ranking by Granisetron Revenue
Table 3. Ranking of Global Top Granisetron Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Granisetron Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transdermal system
Table 6. Key Players of Injection
Table 7. Key Players of Oral
Table 8. COVID-19 Impact Global Market: (Four Granisetron Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Granisetron Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Granisetron Players to Combat Covid-19 Impact
Table 13. Global Granisetron Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Granisetron Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Granisetron Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Granisetron Market Share by Regions (2015-2020)
Table 17. Global Granisetron Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Granisetron Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Granisetron Market Growth Strategy
Table 23. Main Points Interviewed from Key Granisetron Players
Table 24. Global Granisetron Revenue by Players (2015-2020) (Million US$)
Table 25. Global Granisetron Market Share by Players (2015-2020)
Table 26. Global Top Granisetron Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granisetron as of 2019)
Table 27. Global Granisetron by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Granisetron Product Solution and Service
Table 30. Date of Enter into Granisetron Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Granisetron Market Size by Type (2015-2020) (Million US$)
Table 33. Global Granisetron Market Size Share by Type (2015-2020)
Table 34. Global Granisetron Revenue Market Share by Type (2021-2026)
Table 35. Global Granisetron Market Size Share by Application (2015-2020)
Table 36. Global Granisetron Market Size by Application (2015-2020) (Million US$)
Table 37. Global Granisetron Market Size Share by Application (2021-2026)
Table 38. North America Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Granisetron Market Share (2019-2020)
Table 40. North America Granisetron Market Size by Type (2015-2020) (Million US$)
Table 41. North America Granisetron Market Share by Type (2015-2020)
Table 42. North America Granisetron Market Size by Application (2015-2020) (Million US$)
Table 43. North America Granisetron Market Share by Application (2015-2020)
Table 44. Europe Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Granisetron Market Share (2019-2020)
Table 46. Europe Granisetron Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Granisetron Market Share by Type (2015-2020)
Table 48. Europe Granisetron Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Granisetron Market Share by Application (2015-2020)
Table 50. China Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 51. China Key Players Granisetron Market Share (2019-2020)
Table 52. China Granisetron Market Size by Type (2015-2020) (Million US$)
Table 53. China Granisetron Market Share by Type (2015-2020)
Table 54. China Granisetron Market Size by Application (2015-2020) (Million US$)
Table 55. China Granisetron Market Share by Application (2015-2020)
Table 56. Japan Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Granisetron Market Share (2019-2020)
Table 58. Japan Granisetron Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Granisetron Market Share by Type (2015-2020)
Table 60. Japan Granisetron Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Granisetron Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Granisetron Market Share (2019-2020)
Table 64. Southeast Asia Granisetron Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Granisetron Market Share by Type (2015-2020)
Table 66. Southeast Asia Granisetron Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Granisetron Market Share by Application (2015-2020)
Table 68. India Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 69. India Key Players Granisetron Market Share (2019-2020)
Table 70. India Granisetron Market Size by Type (2015-2020) (Million US$)
Table 71. India Granisetron Market Share by Type (2015-2020)
Table 72. India Granisetron Market Size by Application (2015-2020) (Million US$)
Table 73. India Granisetron Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Granisetron Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Granisetron Market Share (2019-2020)
Table 76. Central & South America Granisetron Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Granisetron Market Share by Type (2015-2020)
Table 78. Central & South America Granisetron Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Granisetron Market Share by Application (2015-2020)
Table 80. Kyowa Kirin Company Details
Table 81. Kyowa Kirin Business Overview
Table 82. Kyowa Kirin Product
Table 83. Kyowa Kirin Revenue in Granisetron Business (2015-2020) (Million US$)
Table 84. Kyowa Kirin Recent Development
Table 85. Heron Therapeutics Company Details
Table 86. Heron Therapeutics Business Overview
Table 87. Heron Therapeutics Product
Table 88. Heron Therapeutics Revenue in Granisetron Business (2015-2020) (Million US$)
Table 89. Heron Therapeutics Recent Development
Table 90. Fresenius Kabi Company Details
Table 91. Fresenius Kabi Business Overview
Table 92. Fresenius Kabi Product
Table 93. Fresenius Kabi Revenue in Granisetron Business (2015-2020) (Million US$)
Table 94. Fresenius Kabi Recent Development
Table 95. Hikma Pharmaceuticals Company Details
Table 96. Hikma Pharmaceuticals Business Overview
Table 97. Hikma Pharmaceuticals Product
Table 98. Hikma Pharmaceuticals Revenue in Granisetron Business (2015-2020) (Million US$)
Table 99. Hikma Pharmaceuticals Recent Development
Table 100. Teva Company Details
Table 101. Teva Business Overview
Table 102. Teva Product
Table 103. Teva Revenue in Granisetron Business (2015-2020) (Million US$)
Table 104. Teva Recent Development
Table 105. Cipla Company Details
Table 106. Cipla Business Overview
Table 107. Cipla Product
Table 108. Cipla Revenue in Granisetron Business (2015-2020) (Million US$)
Table 109. Cipla Recent Development
Table 110. Sandoz Company Details
Table 111. Sandoz Business Overview
Table 112. Sandoz Product
Table 113. Sandoz Revenue in Granisetron Business (2015-2020) (Million US$)
Table 114. Sandoz Recent Development
Table 115. Wockhardt Business Overview
Table 116. Wockhardt Product
Table 117. Wockhardt Company Details
Table 118. Wockhardt Revenue in Granisetron Business (2015-2020) (Million US$)
Table 119. Wockhardt Recent Development
Table 120. Mylan Company Details
Table 121. Mylan Business Overview
Table 122. Mylan Product
Table 123. Mylan Revenue in Granisetron Business (2015-2020) (Million US$)
Table 124. Mylan Recent Development
Table 125. APOTEX Company Details
Table 126. APOTEX Business Overview
Table 127. APOTEX Product
Table 128. APOTEX Revenue in Granisetron Business (2015-2020) (Million US$)
Table 129. APOTEX Recent Development
Table 130. Dr.Reddy's Company Details
Table 131. Dr.Reddy's Business Overview
Table 132. Dr.Reddy's Product
Table 133. Dr.Reddy's Revenue in Granisetron Business (2015-2020) (Million US$)
Table 134. Dr.Reddy's Recent Development
Table 135. Bluepharma Company Details
Table 136. Bluepharma Business Overview
Table 137. Bluepharma Product
Table 138. Bluepharma Revenue in Granisetron Business (2015-2020) (Million US$)
Table 139. Bluepharma Recent Development
Table 140. Natco Pharma Company Details
Table 141. Natco Pharma Business Overview
Table 142. Natco Pharma Product
Table 143. Natco Pharma Revenue in Granisetron Business (2015-2020) (Million US$)
Table 144. Natco Pharma Recent Development
Table 145. Akorn Company Details
Table 146. Akorn Business Overview
Table 147. Akorn Product
Table 148. Akorn Revenue in Granisetron Business (2015-2020) (Million US$)
Table 149. Akorn Recent Development
Table 150. Taro Pharmaceutical Company Details
Table 151. Taro Pharmaceutical Business Overview
Table 152. Taro Pharmaceutical Product
Table 153. Taro Pharmaceutical Revenue in Granisetron Business (2015-2020) (Million US$)
Table 154. Taro Pharmaceutical Recent Development
Table 155. Aurobindo Company Details
Table 156. Aurobindo Business Overview
Table 157. Aurobindo Product
Table 158. Aurobindo Revenue in Granisetron Business (2015-2020) (Million US$)
Table 159. Aurobindo Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Granisetron Market Share by Type: 2020 VS 2026
Figure 2. Transdermal system Features
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Global Granisetron Market Share by Application: 2020 VS 2026
Figure 6. Chemotherapy Case Studies
Figure 7. Post operative Case Studies
Figure 8. Granisetron Report Years Considered
Figure 9. Global Granisetron Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Granisetron Market Share by Regions: 2020 VS 2026
Figure 11. Global Granisetron Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Granisetron Market Share by Players in 2019
Figure 14. Global Top Granisetron Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granisetron as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Granisetron Revenue in 2019
Figure 16. North America Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Granisetron Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Kyowa Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Kyowa Kirin Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 25. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Heron Therapeutics Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 27. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Fresenius Kabi Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 29. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Hikma Pharmaceuticals Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 31. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 33. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Cipla Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 35. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sandoz Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 37. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Wockhardt Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 41. APOTEX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. APOTEX Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 43. Dr.Reddy's Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Dr.Reddy's Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 45. Bluepharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Bluepharma Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 47. Natco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Natco Pharma Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 49. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Akorn Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 51. Taro Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Taro Pharmaceutical Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 53. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Aurobindo Revenue Growth Rate in Granisetron Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Request Discount 
Inquire Before Buy